Adage Capital Partners Gp, L.L.C. Ionis Pharmaceuticals Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,075,600 shares of IONS stock, worth $45.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,075,600
Previous 275,000
291.13%
Holding current value
$45.4 Million
Previous $9.61 Million
237.53%
% of portfolio
0.06%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$692 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$683 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$522 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$436 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$356 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...